CHANGING THE WAY WE MAKE
AND TAKE MEDICINES
STEERLife is a unique synergy between engineering and pharmaceutical sciences to create technologies that effectively replace conventional batch processing with true continuous manufacturing and help develop advanced effervescent and other unique drug delivery platforms.
Scroll right to see how STEERLife is revolutionising the batch to continuous (B2C) paradigm
MOVING FROM
‘SWALLOWING’ TO ‘SIPPING’
CLICK HERE TO FIND OUT MORE
<
>
LATEST NEWS
STEERLife Partners With Center for Structured Organic Particulate Systems (C-SOPS) USA
Bio Space, April 18, 2018
IT'S TIME TO CHANGE
“Right now, manufacturing experts from the 1950s would easily recognize the pharmaceutical manufacturing processes of today. It is predicted that manufacturing will change in the next 25 years as current manufacturing practices are abandoned in favor of cleaner, flexible, more efficient continuous manufacturing”
Dr. Janet Woodcock
M.D., Director, USFDA, Center for Drug Evaluation and Research
“The whole industry is discussing continuous manufacturing. The other issue related to mindset is that companies have to change the way they are doing Process R&D, and that takes effort”
Bernhardt Trout
Director of the Novartis-MIT Center for Continuous Manufacturing
“I don’t know why it’s not more widely used as this is the future.”
Dr. Janet Woodcock
M.D., Director, USFDA, Center for Drug Evaluation and Research